Paul A. Ragusa
Director of Finance/CFO at Verax Biomedical, Inc.
Profile
Paul A.
Ragusa is currently the Vice President-Finance & Administration at Verax Biomedical, Inc. He previously worked as a Consultant at Boston Equity Advisors LLC.
He obtained an undergraduate degree from Northeastern University.
Paul A. Ragusa active positions
Companies | Position | Start |
---|---|---|
Verax Biomedical, Inc.
Verax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Verax Biomedical, Inc. develops rapid tests for detecting bacterial contaminants in blood cells and tissues. The firm's first target application for its technology is to test for the presence of bacterial contaminants in platelets and bacterial contaminants in platelets and red blood cells represent the greatest lethal infectious risks in transfusion medicine today and no rapid, simple methods are presently available to effectively address this threat. Verax Biomedical was founded by Joe R. Sanders and Joe L. Straight in 1999 and is headquartered in Marlborough, MA. | Director of Finance/CFO | 2010-03-04 |
Former positions of Paul A. Ragusa
Companies | Position | End |
---|---|---|
Boston Equity Advisors LLC
Boston Equity Advisors LLC Investment Banks/BrokersFinance Boston Equity Advisors LLC is focuses on security brokers, dealers, and flotation companies. The company was founded by Arnold Freedman is headquartered in Canton, MA. | Corporate Officer/Principal | - |
Training of Paul A. Ragusa
Northeastern University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Boston Equity Advisors LLC
Boston Equity Advisors LLC Investment Banks/BrokersFinance Boston Equity Advisors LLC is focuses on security brokers, dealers, and flotation companies. The company was founded by Arnold Freedman is headquartered in Canton, MA. | Finance |
Verax Biomedical, Inc.
Verax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Verax Biomedical, Inc. develops rapid tests for detecting bacterial contaminants in blood cells and tissues. The firm's first target application for its technology is to test for the presence of bacterial contaminants in platelets and bacterial contaminants in platelets and red blood cells represent the greatest lethal infectious risks in transfusion medicine today and no rapid, simple methods are presently available to effectively address this threat. Verax Biomedical was founded by Joe R. Sanders and Joe L. Straight in 1999 and is headquartered in Marlborough, MA. | Commercial Services |
- Stock Market
- Insiders
- Paul A. Ragusa